March 15, 2011

A drug under investigation as a treatment for a rare genetic disorder that causes abnormally high triglyceride levels in the blood has received orphan-drug designation from the Food and Drug Administration.

March 11, 2011

A late-stage trial of a biologic treatment for Type 1 diabetes appears to have failed, according to results announced Friday.

March 7, 2011

The board of directors of Genzyme unanimously recommended that shareholders accept French drug maker Sanofi-Aventis’ $74-per-share buyout offer, Genzyme said Monday.

February 16, 2011

French drug maker Sanofi-Aventis will acquire U.S. biotech giant Genzyme for $20.1 billion, under an agreement the two companies announced Wednesday.

February 8, 2011

The Food and Drug Administration has given expedited review to a drug for preventing hemodialysis failure in patients with end-stage kidney disease.

January 20, 2011

The Food and Drug Administration and Health Canada have granted priority review to a drug for treating hepatitis C.

January 10, 2011

It appears that French drug maker Sanofi-Aventis’ efforts to acquire U.S. biotech company Genzyme are getting somewhere, according to company and media reports.

December 13, 2010

Biotech company Genzyme still is saying “no thanks” to French drug maker Sanofi-Aventis’ tender offer of $18.5 billion, or $69 per share, to acquire it, saying the offer “substantially undervalues” the company.

December 7, 2010

Drug makers Momenta Pharmaceuticals and Sandoz have filed a lawsuit against Teva Pharmaceutical Industries in the U.S. District Court for the District of Massachusetts, alleging infringement of two patents related to a generic blood-thinning drug.

November 17, 2010

Biotech company Genzyme Corp. is selling its diagnostics business to Sekisui Chemical Co. for $265...

November 14, 2010

Poor medication adherence is one of the nation’s “most persistent” healthcare problems, costing the U.S....

November 2, 2010

A company that develops drugs for treating autoimmune diseases and cancer has created a scientific...

October 7, 2010

The board of directors of Genzyme again has rejected a buyout offer by French drug...

October 3, 2010

French drug maker Sanofi-Aventis has launched a hostile takeover bid to take over Cambridge, Mass.-based...

September 12, 2010

Laboratory Corp. of America Holdings will purchase a clinical testing business from Genzyme, Genzyme said...

September 8, 2010

British drug maker Shire is working with Cambridge, Mass.-based Acceleron Pharma to develop treatments for...

August 30, 2010

After Sanofi-Aventis sent Genzyme a second proposal letter to acquire the drug maker on Monday,...

August 5, 2010

Biotech company Genzyme and Isis Pharmaceuticals have finished late-stage clinical trials of a cholesterol-lowering drug,...

April 12, 2010

Some patients stop taking their prescribed medications because they think it interferes with personal priorities...

February 21, 2010

Novartis has received Food and Drug Administration approval for a vaccine for meningococcal disease, the...

November 27, 2007

The Natural Dentist, a natural oral care company, teamed up with renowned body language expert...